PD-1+ T-Cells Correlate with Nerve Fiber Density as a Prognostic Biomarker in Patients with Resected Perihilar Cholangiocarcinoma

Abstract

Background and Aims: Perihilar cholangiocarcinoma (pCCA) is a hepatobiliary malignancy, with a dismal prognosis. Nerve fiber density (NFD)—a novel prognostic biomarker—describes the density of small nerve fibers without cancer invasion and is categorized into high numbers and low numbers of small nerve fibers (high vs low NFD). NFD is different than perineural invasion (PNI), defined as nerve fiber trunks invaded by cancer cells. Here, we aim to explore differences in immune cell populations and survival between high and low NFD patients. Approach and Results: We applied multiplex immunofluorescence (mIF) on 47 pCCA patients and investigated immune cell composition in the tumor microenvironment (TME) of high and low NFD. Group comparison and oncological outcome analysis was performed. CD8+PD-1 expression was higher in the high NFD than in the low NFD group (12.24 × 10−6 vs. 1.38 × 10−6 positive cells by overall cell count, p = 0.017). High CD8+PD-1 expression was further identified as an independent predictor of overall (OS; Hazard ratio (HR) = 0.41; p = 0.031) and recurrence-free survival (RFS; HR = 0.40; p = 0.039). Correspondingly, the median OS was 83 months (95% confidence interval (CI): 18–48) in patients with high CD8+PD-1+ expression compared to 19 months (95% CI: 5–93) in patients with low CD8+PD-1+ expression (p = 0.018 log rank). Furthermore, RFS was significantly lower in patients with low CD8+PD-1+ expression (14 months (95% CI: 6–22)) compared to patients with high CD8+PD-1+ expression (83 months (95% CI: 17–149), p = 0.018 log rank). Conclusions: PD-1+ T-cells correlate with high NFD as a prognostic biomarker and predict good survival; the biological pathway needs to be investigated.

High density and proximity of CD8+T cells to tumor cells are correlated with better response to nivolumab treatment in metastatic pleural mesothelioma

“…These studies suggest that CD8 + T cells as cytotoxic T cells could directly target malignant cells, resulting in activated immunity. In addition, certain CD8 + T cell subpopulations (such as TCF7 + CD8 + T cells and PD‐1 + CD8 + T cells) show a favorable correlation with survival and response to anti‐PD‐1 therapy 39–42 . Therefore, comprehensive categorization of CD8 + TILs may be helpful for patient selection and stratification when considering the indication of ICIs.…”

Multimodal single-cell profiling reveals cancer crosstalk between macrophages and stromal cells in poor prognostic cholangiocarcinoma patients

“…Sections were cut using a Leica RM2235 microscope at a thickness of approximately 4 μm. Antibodies against CK19, CD4, CD8, CD103, and PD-1 were analyzed, and their co-expression was quantified using the TissueFAXS PLUS scanning system with StrataQuest Analysis Software from TissueGnostics(68), Vienna, Austria.…”

Prognostic value of programmed cell death ligand 1 expression in patients with intrahepatic cholangiocarcinoma: a meta-analysis

“…Subsequently, we excluded 107 duplicates, 182 records after screening the titles and abstracts, and 30 records due to irrelevant or incomplete data. Eventually, ten trials (22,(31)(32)(33)(34)(35)(36)(37)(38)(39) and 1944 cases were included according to the inclusion and exclusion criteria (Figure 1).…”